Literature DB >> 9572757

Secondary prevention in coronary heart disease: baseline survey of provision in general practice.

N C Campbell1, J Thain, H G Deans, L D Ritchie, J M Rawles.   

Abstract

OBJECTIVE: To determine secondary preventive treatment and habits among patients with coronary heart disease in general practice.
DESIGN: Process of care data on a random sample of patients were collected from medical records. Health and lifestyle data were collected by postal questionnaire (response rate 71%).
SETTING: Stratified, random sample of general practices in Grampian.
SUBJECTS: 1921 patients aged under 80 years with coronary heart disease identified from pre-existing registers of coronary heart disease and nitrate prescriptions. MAIN OUTCOME MEASURES: Treatment with aspirin, beta blockers, and angiotensin converting enzyme inhibitors. Management of lipid concentrations and hypertension according to local guidelines. Dietary habits (dietary instrument for nutritional evaluation score), physical activity (health practice indices), smoking, and body mass index.
RESULTS: 825/1319 (63%) patients took aspirin. Of 414 patients with recent myocardial infarction, 131 (32%) took beta blockers, and of 257 with heart failure, 102 (40%) took angiotensin converting enzyme inhibitors. Blood pressure was managed according to current guidelines for 1566 (82%) patients but lipid concentrations for only 133 (17%). 673 of 1327 patients (51%) took little or no exercise, 245 of 1333 (18%) were current smokers, 808 of 1264 (64%) were overweight, and 627 of 1213 (52%) ate more fat than recommended.
CONCLUSION: In terms of secondary prevention, half of patients had at least two aspects of their medical management that were suboptimal and nearly two thirds had at least two aspects of their health behaviour that would benefit from change. There seems to be considerable potential to increase secondary prevention of coronary heart disease in general practice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572757      PMCID: PMC28543          DOI: 10.1136/bmj.316.7142.1430

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

1.  Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland.

Authors:  F G Whitelaw; S L Nevin; R M Milne; R J Taylor; M W Taylor; A H Watt
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

2.  Managing established coronary heart disease.

Authors:  M Moher; T Schofield; S Weston; E Fullard
Journal:  BMJ       Date:  1997-07-12

Review 3.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

4.  Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk.

Authors:  M E Cupples; A McKnight
Journal:  BMJ       Date:  1994-10-15

5.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors:  T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

6.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Dietary intervention in primary care: validity of the DINE method for diet assessment.

Authors:  L Roe; C Strong; C Whiteside; A Neil; D Mant
Journal:  Fam Pract       Date:  1994-12       Impact factor: 2.267

9.  Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial.

Authors:  L I Katzel; E R Bleecker; E G Colman; E M Rogus; J D Sorkin; A P Goldberg
Journal:  JAMA       Date:  1995-12-27       Impact factor: 56.272

10.  Management of angina pectoris in general practice: a questionnaire survey of general practitioners.

Authors:  M M Gandhi; F C Lampe; D A Wood
Journal:  Br J Gen Pract       Date:  1995-01       Impact factor: 5.386

View more
  64 in total

1.  Treating dyslipidaemia in primary care. The gap between policy and reality is large in the UK.

Authors:  D Monkman
Journal:  BMJ       Date:  2000-11-25

2.  Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.

Authors:  D Kernick
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

3.  Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.

Authors:  L D Ritchie
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  The primary prevention of coronary heart disease with statins: practice headache or public health?

Authors:  P H Evans
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

5.  [Ischaemic cardiopathy: do we practice secondary prevention in primary care?].

Authors:  E López Núñez; E Rubio Benito; C Pérez Aznar
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

6.  General practice workload implications of the national service framework for coronary heart disease: cross sectional survey.

Authors:  J Hippisley-Cox; M Pringle
Journal:  BMJ       Date:  2001-08-04

7.  Secondary prevention in 24, 431 patients with coronary heart disease: survey in primary care.

Authors:  A J Brady; M A Oliver; J B Pittard
Journal:  BMJ       Date:  2001-06-16

8.  Cardiac rehabilitation.

Authors:  J Dinnes; J Kleijnen; M Leitner; D Thompson
Journal:  Qual Health Care       Date:  1999-03

9.  Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers.

Authors:  J Morrell
Journal:  BMJ       Date:  1999-05-22

10.  Reducing the risk of recurrent coronary heart disease. We know a bit more about what doesn't work.

Authors:  F Bradley; M E Cupples
Journal:  BMJ       Date:  1999-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.